Results 341 to 350 of about 691,603 (403)

Evaluating thresholds of Mac-2 binding protein glycosylation isomer in association with clinical outcomes in patients with cirrhosis. [PDF]

World J Hepatol
Doan TH, Nguyen KM, Nguyen XV, Pham ATN, Le ND.   +4 more
europepmc   +1 more source

Evaluation of the Pharmacokinetics, Disposition, and Metabolism of Miricorilant, a Novel Glucocorticoid Receptor Modulator for the Treatment of Metabolic Dysfunction‐Associated Steatohepatitis in Nonclinical and Clinical Studies

The Journal of Clinical Pharmacology, EarlyView.
Abstract Miricorilant is a novel selective glucocorticoid receptor (GR) modulator with mixed agonist/antagonist effects at the GR and modest antagonism at the mineralocorticoid receptor that is being developed for the treatment of metabolic dysfunction‐associated steatohepatitis.
Hazel J. Hunt, Kirsteen M. Donaldson, Jeevan R. Kunta, Joseph M. Custodio   +3 more
wiley   +1 more source

Causal association between dietary factors and Primary Biliary Cholangitis: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Luo H, Han L, He K, Chen K, Wei Q, Zhang C, Jiang L.   +6 more
europepmc   +1 more source

Plasma atrial natriuretic factor in patients with cirrhosis [PDF]

, 1985
Arendt, Rainer M., Gerbes, Alexander L., Jüngst, Dieter, Paumgartner, Gustav, Ritter, D., Zähringer, J.   +5 more
core  

In Vitro and Clinical Evaluation of Potential Interactions of Bemnifosbuvir with Drug Transporters

The Journal of Clinical Pharmacology, EarlyView.
Abstract Bemnifosbuvir is a novel oral guanosine nucleotide prodrug candidate for the treatment of chronic hepatitis C virus infection. Potential drug–drug interactions (DDIs) of bemnifosbuvir as a substrate or perpetrator with regard to ATP‐binding cassette (ABC) and solute carrier (SLC) transporters were evaluated in vitro and in clinical studies ...
Xiao‐Jian Zhou, Alex Vo, Gaetano Morelli, Maureen Montrond, Shannan Lynch, Keith Pietropaolo, Bruce Belanger, Arantxa Horga, Nancy Agrawal, Janet Hammond   +9 more
wiley   +1 more source

Alcohol-related liver disease. [PDF]

Gastroenterol Rep (Oxf)
Herms Q, Gratacós-Ginès J, Pose E.
europepmc   +1 more source

Outcomes of Patients With Unresectable Cholangiocarcinoma After Portal Vein Embolization: A Propensity Score‐Matched Analysis

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background This study aimed to evaluate the outcomes of patients with unresectable cholangiocarcinoma (CCA) who underwent portal vein embolization (PVE) with a focus on overall survival (OS) and the frequency of biliary drainage (BD). Methods In this retrospective analysis, we evaluated 255 patients with unresectable CCA; 56 patients underwent
Ho Seung Lee, Tae Jun Song, Sung Hyun Cho, Gunn Huh, Dongwook Oh, Jae Min Lee, Jae Hoon Lee, Dae Wook Hwang, Dong‐Wan Seo   +8 more
wiley   +1 more source

Exploring a potential novel marker for short-term mortality in decompensated cirrhosis: insights from a multicentre study. [PDF]

Ann Med
Cheng J, Ju H, Wang G, He C, Wang W.
europepmc   +1 more source

Thermostable enzyme isoforms, continuously producing monocomponent superoxide radicals, from human postoperative serous fluids: isolation and properties. [PDF]

BMC Cancer
Simonyan RM, Babayan MA, Yekmalyan HH, Simonyan SG, Papazyan KT, Stepanyan SA, Sarkavagyan HK, Simonyan GM, Darbinyan LV, Simonyan KV, Chailyan SG, Simonyan MA.   +11 more
europepmc   +1 more source

Identification of Key Gene Related to Matrisome in HBV-Associated Liver Cirrhosis via Bioinformatics Analysis. [PDF]

Int J Hepatol
Chaulagain RP, Shrestha Y, Dinislam K, Jin S.   +3 more
europepmc   +1 more source